How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine

被引:145
|
作者
McMurray, John J. V. [1 ]
Packer, Milton [2 ]
机构
[1] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland
[2] Baylor Univ, Med Ctr, Dallas, TX USA
关键词
adrenergic beta-antagonists; aldosterone; angiotensin converting enzyme inhibitors; heart failure; neprilysin; receptors; mineralocorticoid; sodium-glucose transport proteins; MORTALITY;
D O I
10.1161/CIRCULATIONAHA.120.052926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:875 / 877
页数:3
相关论文
共 50 条
  • [21] The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
    Kiel, Richard. G.
    Deedwania, Prakash
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1855 - 1863
  • [22] Novel Medical Treatments and Devices for the Management of Heart Failure with Reduced Ejection Fraction
    Alfieri, Michele
    Bruscoli, Filippo
    Di Vito, Luca
    Di Giusto, Federico
    Scalone, Giancarla
    Marchese, Procolo
    Delfino, Domenico
    Silenzi, Simona
    Martoni, Milena
    Guerra, Federico
    Grossi, Pierfrancesco
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (04)
  • [23] The Dilemma of Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction: Are We Waiting Too Long to Intervene, or Should We Wait for More Evidence?
    Cormican, Daniel S.
    Czerny, Martin
    Ramakrishna, Harish
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (01) : 15 - 17
  • [24] A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
    Reddy, Yogesh N. V.
    Carter, Rickey E.
    Obokata, Masaru
    Redfield, Margaret M.
    Borlaug, Barry A.
    CIRCULATION, 2018, 138 (09) : 861 - 870
  • [25] A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction
    Nguyen, Elaine
    Weeda, Erin R.
    White, C. Michael
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (08): : 936 - 947
  • [26] Mechanical dyssynchrony in patients with heart failure and reduced ejection fraction: how to measure?
    Khidir, Mand J. H.
    Delgado, Victoria
    Marsan, Nina Ajmone
    Bax, Jeroen J.
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (05) : 523 - 530
  • [27] Cardiac rehabilitation in heart failure with reduced ejection fraction: A "should take it and not leave it" intervention
    Taylor, Rod
    Dalal, Hayes
    Davies, Russell
    Doherty, Patrick
    Jolly, Kate
    Lang, Chim
    Wingham, Jenny
    AMERICAN HEART JOURNAL, 2017, 192 : E1 - E2
  • [28] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [29] Evidence-based medicine: How do we find the evidence?
    Odunsi, KO
    Cooke, IE
    Olive, DL
    JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 1998, 5 (03): : 313 - 318
  • [30] Improving female enrolment in randomized clinical trials of heart failure with reduced ejection fraction to ensure evidence-based health care recommendations
    Schneider, Birke
    Ong, Peter
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (01) : 25 - 26